More on Lialda ruling

|By:, SA News Editor

Actavis (ACT) confirms the reversal of the U.S. District Court of the Southern District of Florida ruling that the firm's generic mesalamine infringes on a Lialda patent.

The U.S. Court of Appeals found that the District Court failed to correctly interpret the claims of the '720 patent. It remands the case back to the District Court for further proceedings based on the Appeals Court's rulings.

Shire plc (SHPG) finished today's trading down 1% at $149.67.